These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 23481228)

  • 1. Editorial comment.
    Hegele RA
    Curr Opin Lipidol; 2013 Apr; 24(2):109-10. PubMed ID: 23481228
    [No Abstract]   [Full Text] [Related]  

  • 2. Regression of atherosclerosis demands low LDL targets and raised HDL levels.
    Cardiovasc J Afr; 2008; 19(4):221. PubMed ID: 18776971
    [No Abstract]   [Full Text] [Related]  

  • 3. Apolipoprotein B (apoB) more closely related to subclinical atherosclerosis than non-HDL cholesterol and LDL cholesterol.
    Walldius G
    J Intern Med; 2010 Dec; 268(6):549-51. PubMed ID: 21091807
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum uric acid: marker for atherosclerosis as it is positively associated with "atherogenic index of plasma".
    Baliarsingh S; Sharma N; Mukherjee R
    Arch Physiol Biochem; 2013 Feb; 119(1):27-31. PubMed ID: 23083415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk.
    Holewijn S; den Heijer M; Swinkels DW; Stalenhoef AF; de Graaf J
    J Intern Med; 2010 Dec; 268(6):567-77. PubMed ID: 21091808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dyslipidemia].
    Mashimo Y; Maeda T; Teramoto T
    Nihon Rinsho; 2012 May; 70(5):852-6. PubMed ID: 22620012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HDL-cholesterol-- active or passive participant in the pathogenesis of atherosclerosis].
    Artenie R; Ungureanu D; Artenie A; Botnariu G; Anisie E
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):282-7. PubMed ID: 14755929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipid therapy in risk patients. Do we concentrate too much on LDL cholesterol?].
    März W
    MMW Fortschr Med; 2005 Apr; 147(14):14. PubMed ID: 15887675
    [No Abstract]   [Full Text] [Related]  

  • 9. Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study.
    Pertovaara M; Raitala A; Juonala M; Lehtimäki T; Huhtala H; Oja SS; Jokinen E; Viikari JS; Raitakari OT; Hurme M
    Clin Exp Immunol; 2007 Apr; 148(1):106-11. PubMed ID: 17349013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lower LDL and/or raise HDL. In what direction is lipidology moving?].
    Parhofer KG
    MMW Fortschr Med; 2007 May; 149(22):27. PubMed ID: 18069222
    [No Abstract]   [Full Text] [Related]  

  • 11. [Homocystein serum levels and lipid parameters in children with atherosclerosis risk factors].
    Sierakowska-Fijałek A; Kaczmarek P; Pokoca L; Smorag I; Wosik-Erenbek M; Baj Z
    Pol Merkur Lekarski; 2007 Feb; 22(128):146-9. PubMed ID: 17598661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HDL-cholesterol--active or passive participant in the pathogenesis of atherosclerosis? (II)].
    Artenie A; Artenie R; Ungureanu D; Botnariu G; Anisies E; Ionescu SD; Cosovanu A
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(3):503-8. PubMed ID: 15832963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When good cholesterol turns bad.
    Pearson H
    Nature; 2006 Dec; 444(7121):794-5. PubMed ID: 17167436
    [No Abstract]   [Full Text] [Related]  

  • 14. Atherosclerosis: who gets it and how it gets there.
    Ducas J
    Can J Cardiol; 1993 Mar; 9(2):160-1. PubMed ID: 8490785
    [No Abstract]   [Full Text] [Related]  

  • 15. Can lipid and lipoprotein concentrations in childhood predict adult atherosclerosis?
    Daniels SR
    J Am Coll Cardiol; 2009 Mar; 53(10):870-1. PubMed ID: 19264244
    [No Abstract]   [Full Text] [Related]  

  • 16. Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?
    Sniderman A; McQueen M; Contois J; Williams K; Furberg CD
    J Clin Lipidol; 2010; 4(3):152-5. PubMed ID: 21122647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The apoB/apoA-I ratio is better myocardial infarction marker than lipids].
    Walldius G; Angelin B; Eriksson M
    Lakartidningen; 2006 Mar 8-14; 103(10):751-2. PubMed ID: 16610201
    [No Abstract]   [Full Text] [Related]  

  • 18. [Can higher level of HDL cholesterol augment cardiovascular disease prevention? The combination statins-nicotinic acid increases the level of HDL and reduces the level of LDL cholesterol].
    Carlson LA
    Lakartidningen; 2006 Oct 25-31; 103(43):3283-5. PubMed ID: 17117660
    [No Abstract]   [Full Text] [Related]  

  • 19. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up with HDL, the "good" cholesterol. Guidelines mainly target LDL cholesterol, but HDL matters, too.
    Harv Womens Health Watch; 2008 Jun; 15(10):2-3. PubMed ID: 18853517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.